ESMO 2017: One in four small and early-stage breast cancers can be aggressive and benefit from adjuvant chemotherapy

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • One in four patients with T1abN0 breast tumours of less than 1 cm can benefit from adjuvant chemotherapy.

Why this matters

  • The study challenges the assumption that all patients with small breast tumours clinically classified as low-risk can avoid adjuvant chemotherapy after...